Effects of cannabis

Survey On Driving After Alcohol, Cannabis Or Illicit Drug Use Reveals Disturbing Rates, Excuses, Misperceptions

Retrieved on: 
Tuesday, June 29, 2021
Psychoactive drugs, Cannabis smoking, Health sciences, Herbalism, Medicinal plants, Branches of biology, Driving under the influence, MADD Canada, Cannabis, Effects of cannabis, Opioid, Medical cannabis

Among the 9% of drivers who used a non-prescribed illicit drug (stimulant, depressant, hallucinogen, opioid, etc.)

Key Points: 
  • Among the 9% of drivers who used a non-prescribed illicit drug (stimulant, depressant, hallucinogen, opioid, etc.)
  • A disturbing number of people are driving knowing they are impaired by alcohol, cannabis, or an illicit drug, and very often have passengers with them, said MADD Canada Chief Executive Officer Andrew Murie.
  • Mr. Murie noted that the survey provides valuable data on the impact of the opioid crisis on impaired driving.
  • Excuses For Driving After Alcohol, Cannabis Or Illicit Drug Use
    The reasons survey respondents gave for driving after consuming alcohol, cannabis or an illicit drug are both frustrating and familiar to MADD Canada.

BC Craft Supply Co Announces Operational Update and Strategic Expansion into United States National CBD Market

Retrieved on: 
Tuesday, June 29, 2021
Psychoactive drugs, Medicinal plants, Entheogens, Euphoriants, Branches of biology, Drugs, Herbalism, Appetite stimulants, Cannabis, Medical cannabis, Tetrahydrocannabinol, Effects of cannabis

CRFT will undergo a strategic refocus on growth segments; leveraging Canadian cannabis expertise in the United States cannabis and CBD markets and directing regulatory expertise in Canada towards licensure in psychedelics.

Key Points: 
  • CRFT will undergo a strategic refocus on growth segments; leveraging Canadian cannabis expertise in the United States cannabis and CBD markets and directing regulatory expertise in Canada towards licensure in psychedelics.
  • FeelWell will launch a national direct-to-consumer (D2C) CBD brand through strategic partnerships, large-scale facility partners, and product innovation-driven from CRFT in Canada.
  • United States Recreational Cannabis: FeelWell will build distribution of a focused product range in the $11B California recreational THC market, which represents 15% of the total USA cannabis market.
  • BC Craft Supply Co Ltd. is a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy.

Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights

Retrieved on: 
Tuesday, June 29, 2021
Retail, Specialty, Other Retail, Cannabis smoking, Psychoactive drugs, Aphria, Tilray, Drugs, Cannabis, Effects of cannabis, Companies

Tilray is also asking stockholders to approve certain amendments and modifications to Tilrays organizational documents to provide for increased shareholder rights.

Key Points: 
  • Tilray is also asking stockholders to approve certain amendments and modifications to Tilrays organizational documents to provide for increased shareholder rights.
  • Through our recent combination with Aphria Inc., we have ushered in a new era for the global cannabis industry.
  • We now have the largest geographic footprint and leading cannabis-focused portfolio of consumer-packaged goods in the world.
  • We Have Substantial Growth Opportunities Ahead and We Need Your Support: To go from potential to performance, however, we need your help.

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Retrieved on: 
Tuesday, June 29, 2021
Other Health, Health, Science, Pharmaceutical, Research, Cannabis, Psychoactive drugs, Health sciences, Herbalism, Medicinal plants, Cannabis smoking, Entheogens, Curaleaf, Cannabis culture, Medical cannabis, Effects of cannabis, Curaleaf International, Zambon Spa, CURALEAF INTERNATIONAL, ZAMBON SPA

The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.

Key Points: 
  • The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.
  • "We are delighted to be announcing this partnership with Zambon today, and to be working with a leading pharmaceutical company to create the first European pharmaceutical and medical cannabis partnership; we believe it is testament to our continued commitment to research-led product excellence at Curaleaf International," says Curaleaf International CEO, Antonio Costanzo.
  • Since 2017, cannabis has been approved for therapeutic use in Germany and may be prescribed by doctors for serious illnesses.
  • Curaleaf International assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

TransMedia Group to Serve Culinary Cannabis Maverick 'JeffThe420Chef' up to a Mainstream Media World Hungry For a Tasty Story

Retrieved on: 
Monday, June 28, 2021
Cannabis smoking, Psychoactive drugs, Cannabis, Storytelling, Transmedia storytelling, Drugs, Effects of cannabis, Herb, Odor

TransMedia will highlight how JeffThe420Chef brings the cannabis consumption experience into the mainstream, having invented the process which cleans and neutralizes the herbaceous taste and odor of the plant.

Key Points: 
  • TransMedia will highlight how JeffThe420Chef brings the cannabis consumption experience into the mainstream, having invented the process which cleans and neutralizes the herbaceous taste and odor of the plant.
  • "Cannabis is a gateway to a better quality of life for people," said Jeff Danzer, a.k.a.
  • JeffThe420Chef.
  • TransMedia Group plans to arrange for JeffThe420Chef to have speaking opportunities, press interviews, TV appearances, and conferences with other professionals.

Clever Leaves Launches Project Change Lives, Pledging $25M Worth of Medical Cannabis to U.S. Researchers

Retrieved on: 
Monday, June 28, 2021
Medicinal plants, Health sciences, Psychoactive drugs, Entheogens, Euphoriants, Cannabis smoking, Herbalism, Medicine, Cannabis, Effects of cannabis, Medical cannabis, Cannabis industry

By sponsoring Project Change Lives, Clever Leaves is offering to provide a historic amount of pharmaceutical-grade cannabis to leading research institutions in one of the most advanced pharmaceutical markets in the world.

Key Points: 
  • By sponsoring Project Change Lives, Clever Leaves is offering to provide a historic amount of pharmaceutical-grade cannabis to leading research institutions in one of the most advanced pharmaceutical markets in the world.
  • Clever Leaves is looking to supply up to 250,000 bottles of pharmaceutical-grade cannabis oils or approximately 5 tons of medical cannabis flower that will help research institutions develop new therapies.
  • To eliminate an additional impediment to the advancement of scientific knowledge around cannabis, this research material will be provided at no cost to Clever Leaves research partners.
  • Clever Leaves is launching, in close collaboration with a distinguished scientific and medical review panel, a nationwide call for proposals from researchers at universities and accredited facilities seeking medical cannabis to conduct their studies.

Ayr Wellness Announces Results of Annual General and Special Meeting and Termination of Voting Agreements

Retrieved on: 
Friday, June 25, 2021
Cannabis smoking, Psychoactive drugs, Towns in the United Kingdom, Ayr, Firth of Clyde, Cannabis, Effects of cannabis, OTC Markets Group, Geography of Scotland

TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (Ayr or the Company), a vertically-integrated cannabis multi-state operator (MSO), is pleased to announce the voting results from its annual general and special meeting of shareholders held on June 24, 2021 (the Meeting).

Key Points: 
  • TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (Ayr or the Company), a vertically-integrated cannabis multi-state operator (MSO), is pleased to announce the voting results from its annual general and special meeting of shareholders held on June 24, 2021 (the Meeting).
  • A copy of the Circular is, and Ayrs revised articles will be, available on SEDAR at www.sedar.com under Ayrs profile.
  • Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator, focused on delivering the highest quality cannabis products and customer experience throughout its footprint.
  • Ayr strives to enrich consumers experience every day through the wellness and wonder of cannabis.

Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders

Retrieved on: 
Friday, June 25, 2021
Cronos, Lluís Companys, Effects of cannabis, Spanish politicians, Government of Spain, Politicians

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Companys SEDAR profile at www.sedar.com and the Companys Form 8-K filed on EDGAR at www.sec.gov/edgar.

Key Points: 
  • For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Companys SEDAR profile at www.sedar.com and the Companys Form 8-K filed on EDGAR at www.sec.gov/edgar.
  • Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents.
  • Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
  • With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio.

American Council of Cannabis Medicine Announces 'Yes We Cann!" Program to Support Major Index and Elevated States Programs

Retrieved on: 
Friday, June 25, 2021
Health sciences, Cannabis smoking, Herbalism, Medicinal plants, Psychoactive drugs, Medicine, ACCM, Effects of cannabis, Cannabis, Medical cannabis

WASHINGTON, June 25, 2021 /PRNewswire/ -- The American Council of Cannabis Medicine (ACCM) announced today, support for two major initiatives further accelerating access, research and professionalization of medical cannabis.

Key Points: 
  • WASHINGTON, June 25, 2021 /PRNewswire/ -- The American Council of Cannabis Medicine (ACCM) announced today, support for two major initiatives further accelerating access, research and professionalization of medical cannabis.
  • The National Medcann Index and Elevated States programs bring together multiple stakeholders in cooperation with ACCM's "Yes We Cann!"
  • MedCann Index and Elevated States are prime examples of how ACCM as the primary Industry Council can make a huge difference.
  • Reach the American Council of Cannabis Medicine at 202-349-9650, or visit www.accmforum.org .

CBD of Denver Comments on Formation of Medical Cannabis Committee by Spain's Congress

Retrieved on: 
Thursday, June 24, 2021
Medicinal plants, Psychoactive drugs, Cannabis, Health sciences, Herbalism, Entheogens, Euphoriants, Cannabis smoking, Medical cannabis, Hemp, Effects of cannabis, Outline of cannabis

Denver, Colorado--(Newsfile Corp. - June 24, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp oil company and a producer and distributor of cannabis and CBD products in Switzerland, Europe, and the US, comments on the passage of a measure in Spain's Congress that creates a subcommittee dedicated to researching medical cannabis policy.

Key Points: 
  • Denver, Colorado--(Newsfile Corp. - June 24, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp oil company and a producer and distributor of cannabis and CBD products in Switzerland, Europe, and the US, comments on the passage of a measure in Spain's Congress that creates a subcommittee dedicated to researching medical cannabis policy.
  • The Spanish Congress medical cannabis committee will examine regulated medical cannabis markets in other countries and the growing body of scientific research supporting medical cannabis to evaluate the creation of a regulated domestic medical cannabis industry in Spain.
  • CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.
  • CBD of Denver, Inc. (OTC Pink: CBDD) a full-line CBD and Hemp oil company ("CBDD") and a producer and distributor of Cannabis and CBD products in Switzerland, Europe and the US.